Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma
Introduction: In hepatocellular carcinoma (HCC), alternative splicing (AS) is related to tumor invasion and progression.Methods: We used HCC data from a public database to identify AS subtypes by unsupervised clustering. Through feature analysis of different splicing subtypes and acquisition of the...
Main Authors: | Wangrui Liu, Shuai Zhao, Wenhao Xu, Jianfeng Xiang, Chuanyu Li, Jun Li, Han Ding, Hailiang Zhang, Yichi Zhang, Haineng Huang, Jian Wang, Tao Wang, Bo Zhai, Lei Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1019988/full |
Similar Items
-
Aberrant RNA Splicing in Cancer and Drug Resistance
by: Bi-Dar Wang, et al.
Published: (2018-11-01) -
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
by: Koji Kitamura, et al.
Published: (2021-04-01) -
Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
by: Naoyuki Kataoka, et al.
Published: (2021-07-01) -
Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
by: Zhihui Dou, et al.
Published: (2021-06-01) -
Role of Aberrant Alternative Splicing in Cancer
by: Milad Khorasani, et al.
Published: (2021-06-01)